Advertisement PathXL™ chosen for NIBiobank - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
More info about Path XL

PathXL™ chosen for NIBiobank

CASE STUDIES
By Path XL

NIBiobank selected PathXL ™ Biobank as it was the only solution on the market that could provide a Tissue bank Management System with fully intergrated virtual microscopy. Cancer Research UK together with The Health and Social Care Research and Development Division of the Public Health Agency (HSC R&D Division) and The Friends of the Cancer Centre (FOCC) provided the funding to establish the Northern Ireland Biobank and virtual tissue archive